| PCS | MCS | QOLS | ||||||
---|---|---|---|---|---|---|---|---|---|
 | Adj B | 95% CI | p | Adj B | 95% CI | p | Adj B | 95% CI | p |
Demographic | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Age* | -1.0 | (-1.9, -0.2) | 0.015 | 0.05 | (-1.1, 1.2) | 0.926 | -0.4 | (-1.7, 0.9) | 0.529 |
Male | -0.5 | (-3.8, 2.9) | 0.783 | -2.4 | (-7.0, 2.2) | 0.310 | -1.4 | (-6.5, 3.7) | 0.590 |
Female | Ref | Â | Â | Ref | Â | Â | Ref | Â | Â |
Living alone | -2.9 | (-5.8, 0.0) | 0.050 | 3.5 | (-0.6, 7.5) | 0.093 | -0.1 | (-4.6, 4.4) | 0.968 |
Cohabiting | Ref | Â | Â | Ref | Â | Â | Ref | Â | Â |
Clinical | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Hip patients | -5.8 | (-8.7, -2.8) | < 0.001 | -3.8 | (-7.9, 0.3) | 0.071 | -1.7 | (-6.1, 2.7) | 0.447 |
Controls | Ref | Â | Â | Ref | Â | Â | Ref | Â | Â |
Osteopenia** | -0.8 | (-4.3, 2.8) | 0.671 | -0.5 | (-5.5, 4.5) | 0.837 | -3.2 | (-8.8, 2.4) | 0.265 |
Osteoporosis** | 0.2 | (-3.9, 4.3) | 0.918 | -2.1 | (-7.9, 3.6) | 0.461 | 1.4 | (-4.7, 7.6) | 0.649 |
Normal BMD | Ref | Â | Â | Ref | Â | Â | Ref | Â | Â |
Co-morbidity | 0.0 | (-1.4, 1.4) | 0.999 | -2.2 | (-4.1, -0.2) | 0.029 | -0.3 | (-2.6, 2.0) | 0.783 |
QOL | Â | Â | Â | Â | Â | Â | Â | Â | Â |
PCS incl. | -0.3 | (-0.5, -0.2) | < 0.001 | Â | Â | Â | Â | Â | Â |
MCS incl. | Â | Â | Â | -0.5 | (-0.8, -0.3) | < 0.001 | Â | Â | Â |
QOLS incl. | Â | Â | Â | Â | Â | Â | -0.2 | (-0.5, 0.0) | 0.049 |
R 2 adj | 26.7% | Â | Â | 21.5% | Â | Â | 2.3% | Â | Â |